Home > Insider Trading > Filing (0001179110-12-003400)

Filing Details

Accession Number:: 0001179110-12-003400
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-02-23 21:44:16
Reporting Period:: 2012-02-22

Filing Date:: 2012-02-23
Accepted Time:: 2012-02-23 21:44:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
916085	Health Net Inc	HNT	Hospital & Medical Service Plans (6324)	954288333

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1435524	T. Patricia Clarey	21650 Oxnard Street Woodland Hills CA 91367	Svp, Chief Regulatory Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2012-02-22	730	$38.86	47,858	No	4	F	Direct
Common Stock	Disposition	2012-02-22	500	$38.05	47,358	No	4	S	Direct
Common Stock	Disposition	2012-02-22	4,180	$38.68	43,178	No	4	S	Direct
Common Stock	Disposition	2012-02-23	208	$38.67	42,970	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Shares forfeited in lieu of payment of tax liability in connection with the vesting of 25% of a grant of 6,250 restricted stock units made to the Reporting Person on February 22, 2010 pursuant to the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2010 Grant").
The number of shares forfeited by the Reporting Person was based on the closing price of the Issuer's common stock on February 22, 2012, the vesting date of the 2010 Grant.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.47 to $38.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person on February 22, 2012, as reported on this Form 4, were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.51 to $38.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person on February 22, 2012, as reported on this Form 4, were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.31 to $39.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person on February 23, 2012, as reported on this Form 4, were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
Includes shares held by the Patricia T. Clarey Revocable Trust, of which the Reporting Person is sole trustee and beneficiary.